It’s a really sick market generally with high (relative) interest rates killing liquidity. And the hype trade is over for the moment. Plus biotech is on the nose globally. So it’s really a confluence of factors. Lots of small shareholders dumping stock for cash requirements just adds to the rot.
That all being said Mr Hopper hasn’t helped the cause.
CHM-The only ASX listed CAR-T comp with 2/3 human trials, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |